MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2023 · 87 positions · Total reported value $1.85B · Top-10 concentration 47.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, MONTANOVA CAPITAL, LLC disclosed 87 equity positions with a combined reported value of $1.85B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were RPRX ($111.16M), BHVN ($104.19M), ACLX ($102.97M). By sector, the heaviest allocations are Health Care 40.7%, Technology 17.8%.

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions.

The largest new positions opened in Q3 2023 were RPRX ($111.16M), BHVN ($104.19M), ACLX ($102.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • RPRX ROYALTY PHARMA PLC · $111.16M
  • BHVN BIOHAVEN LTD · $104.19M
  • ACLX ARCELLX INC · $102.97M
  • HZNP HORIZON THERAPEUTICS PUB L · $90.97M
  • INSM INSMED INC · $87.02M
  • META META PLATFORMS INC · $84.25M
  • AMZN AMAZON COM INC · $78.75M
  • AMD ADVANCED MICRO DEVICE LTD. · $71.62M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 40.7%
Technology 17.8%
Financials 2.8%
Other 22.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.10M $111.16M 6.01%
6.01%
New
2 4.01M $104.19M 5.63%
5.63%
New
3 2.87M $102.97M 5.56%
5.56%
New
4 786.31K $90.97M 4.92%
4.92%
New
5 3.45M $87.02M 4.70%
4.70%
New
6 280.64K $84.25M 4.55%
4.55%
New
7 619.47K $78.75M 4.25%
4.25%
New
8 696.51K $71.62M 3.87%
3.87%
New
9 1.37M $71.36M 3.86%
3.86%
New
10 218.17K $68.89M 3.72%
3.72%
New
11 7.34M $66.90M 3.62%
3.62%
New
12 460.05K $42.51M 2.30%
2.30%
New
13 5.20M $41.90M 2.26%
2.26%
New
14 2.69M $41.60M 2.25%
2.25%
New
15 350.97K $38.80M 2.10%
2.10%
New
16 88.55K $38.52M 2.08%
2.08%
New
17 20.40K $37.37M 2.02%
2.02%
New
18 284.49K $32.83M 1.77%
1.77%
New
19 6.04M $30.39M 1.64%
1.64%
New
20 3.05M $29.77M 1.61%
1.61%
New
21 642.83K $29.47M 1.59%
1.59%
New
22 3.49M $27.90M 1.51%
1.51%
New
23 255.31K $27.04M 1.46%
1.46%
New
24 5.72M $25.39M 1.37%
1.37%
New
25 679.46K $24.22M 1.31%
1.31%
New
26 2.42M $23.31M 1.26%
1.26%
New
27 80.99K $21.41M 1.16%
1.16%
New
28 39.10K $21.00M 1.14%
1.14%
New
29 5.88M $20.42M 1.10%
1.10%
New
30 1.01M $20.31M 1.10%
1.10%
New
31 2.85M $18.81M 1.02%
1.02%
New
32 353.74K $18.68M 1.01%
1.01%
New
33 3.87M $17.71M 0.96%
0.96%
New
34 181.66K $17.63M 0.95%
0.95%
New
35 428.51K $17.51M 0.95%
0.95%
New
36 191.90K $17.22M 0.93%
0.93%
New
37 113.96K $17.11M 0.93%
0.93%
New
38 5.73M $17.09M 0.92%
0.92%
New
39 37.54K $16.32M 0.88%
0.88%
New
40 90.10K $14.03M 0.76%
0.76%
New
41 27.22K $13.73M 0.74%
0.74%
New
42 2.96M $11.47M 0.62%
0.62%
New
43 454.00K $11.24M 0.61%
0.61%
New
44 597.10K $10.72M 0.58%
0.58%
New
45 7.36M $9.50M 0.51%
0.51%
New
46 479.44K $8.61M 0.47%
0.47%
New
47 7.17M $8.53M 0.46%
0.46%
New
48 928.40K $8.47M 0.46%
0.46%
New
49 116.04K $6.22M 0.34%
0.34%
New
50 536.50K $6.03M 0.33%
0.33%
New

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, MONTANOVA CAPITAL, LLC reported 87 equity positions worth $1.85B in aggregate; its largest disclosed positions were RPRX ($111.16M), BHVN ($104.19M), ACLX ($102.97M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $1.85B of long equity holdings across 87 positions as of 2023-Q3. Top-10 holdings account for 47.1% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →